tamsulosin has been researched along with Lower Urinary Tract Symptom in 132 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 107 (81.06) | 24.3611 |
| 2020's | 25 (18.94) | 2.80 |
| Authors | Studies |
|---|---|
| Alcaraz, A; Angulo, JC; Brenes-Bermúdez, FJ; Carballido-Rodríguez, J; Castro-Díaz, D; Cózar-Olmo, JM; Esteban-Fuertes, M; Fernández-Gómez, JM; Fernández-Pro Ledesma, A; Ficarra, V; Manasanch, J; Medina-Polo, J; Molero-García, JM; Palou, J; Pérez-León, N; Ponce de León Roca, J; Rodríguez-Antolín, A | 1 |
| Kim, AR; Kwon, O; Lee, CL; Lee, JY; Lim, JS; Na, YG; Park, JM; Seo, BN; Seo, CS; Shin, HK; Shin, JH; Song, KH; Yang, SW | 1 |
| Matsuo, T; Miyata, Y; Sakai, H | 1 |
| Kim, JH; Lee, JW | 1 |
| King, B; Plochocki, A | 1 |
| Averbeck, MA; Concas, F; Cortés, V; Gravas, S; Kamola, PJ; Kattan, MW; Lulic, Z; Manyak, M; Oelke, M; Palacios-Moreno, JM; Roehrborn, CG; Thompson, D | 1 |
| Abdullaev, SP; Shatokhin, MN; Sychev, DA; Teodorovich, OV | 1 |
| Lowe, FC; Michel, MC; Verbeek, AE; Wruck, JM | 1 |
| Hashizume, K; Kasamo, S; Matsumoto, S | 1 |
| Gittelman, M; Lowe, FC; Roehrborn, CG; Verbeek, AE; Wruck, JM | 2 |
| Akamatsu, S; Goto, T; Kobayashi, T; Matsubara, K; Matsui, Y; Negoro, H; Ogawa, O; Omura, T; Terada, N; Yamamoto, T; Yonezawa, A | 1 |
| Chapple, C; De Nunzio, C; Frizzi, J; Gacci, M; Gravas, S; Kaplan, SA; Maggi, M; McVary, KT; Saleh, O; Sebastianelli, A; Serni, S; Spatafora, P; Tubaro, A; Vignozzi, L | 1 |
| Chen, YB; Gao, L; Jiang, Q; Luo, RT; Ran, K | 1 |
| Jong, JJ; Kakizaki, H; Katou, D; Lee, KS; Sumarsono, B; Uno, S; Yamaguchi, O; Yamamoto, O | 1 |
| Kaplan, SA | 4 |
| Giuliano, F; Lulic, Z; Manyak, MJ; Palacios-Moreno, JM; Roehrborn, CG; Rosen, RC; Wilson, TH | 1 |
| Huang, H; Huang, WP; Ye, XT; Zhang, FY | 1 |
| Cai, Z; Li, H; Ma, C; Xiong, J; Zhang, J | 1 |
| Chen, X; Guo, B; Hou, H; Liu, M; Wang, M; Zhang, Z | 1 |
| Aydin, M; Bayar, G; Kilinc, MF; Ofluoglu, Y; Yavuz, A | 1 |
| Gupta, S; Singh, I; Tk, A | 1 |
| Ishida, K; Jong, JJ; Kakizaki, H; Katoh, T; Katou, D; Lee, KS; Sumarsono, B; Uno, S; Yamaguchi, O; Yamamoto, O | 1 |
| Aveta, A; Capece, M; Creta, M; Crocetto, F; Esposito, F; Fusco, F; Imbimbo, C; La Rocca, R; Longo, N; Mangiapia, F; Mirone, V; Trama, F | 1 |
| Cambronero Santos, J; Choudhury, N; Foley, S; Hairston, J; Herschorn, S; Kaplan, SA; Kristy, RM; McVary, KT | 1 |
| Chapple, C; Gacci, M; Gravas, S; Kaplan, S; McVary, KT; Morselli, S; Sebastianelli, A; Serni, S; Spatafora, P; Vignozzi, L | 1 |
| Chapple, C; Gacci, M; Gemma, L; Gravas, S; Kaplan, SA; Liaci, A; Maggi, M; McVary, KT; Morselli, S; Sebastianelli, A; Serni, S; Spatafora, P; Vignozzi, L; Zaccaro, C | 1 |
| Chavan, C; D'Agate, S; Della Pasqua, O; Manyak, M; Michel, MC; Oelke, M; Palacios-Moreno, JM; Roehrborn, CG | 1 |
| Kamoto, T; Tsukino, H | 1 |
| Chai, Y; Che, X; Cui, Y; Zhang, Y; Zhou, Z | 1 |
| Guo, J; Tang, R | 1 |
| Ghadian, A; Rezaei, M | 1 |
| Ding, K; He, W; Liu, S; Wu, H; Zhang, T | 1 |
| Cheng, X; Huang, ZG; Liu, TT; Qiu, Y; Zhang, HL; Zou, XQ | 1 |
| Bai, B; Lei, Y; Mu, J; Wang, J; Zhang, T; Zhang, X | 1 |
| Gao, G; Sun, F; Wang, K; Xue, P; Yan, M; Zhang, W | 1 |
| van Moorselaar, RJA; van Waesberghe, JHTM; Vis, AN | 1 |
| Ahn, TY; Hyun, JS; Jung, J; Kim, SW; Lee, SW; Min, KS; Moon, DG; Moon, KH; Park, JK; Park, K; Park, NC; Ryu, JK; Son, H; Yang, DY; Yang, SK | 1 |
| Govorov, AV; Pushkar, DY; Vasilyev, AO | 1 |
| Giuliano, F; Karanastasis, D; Manyak, MJ; Palacios-Moreno, JM; Plastino, J; Roehrborn, CG; Roos, EPM; Rosen, RC; Santos, JC; Wilson, TH | 1 |
| Di Clemente, L; Di Pasquale, AB; Masciovecchio, S; Ranieri, G; Romano, G | 1 |
| Schaeffer, EM | 1 |
| Chen, CL; Hou, CP; Lin, YH; Tsui, KH; Yang, PS | 1 |
| Bae, JH; Chang, IH; Chung, JH; Chung, JI; Ha, US; Han, DH; Han, JH; Jung, J; Kim, JH; Kim, SW; Kim, TH; Kim, YI; Lee, SH; Lee, SW; Oh, CY; Yoo, TK | 1 |
| Albertsen, PC; Duan, Y; Frankel, JK | 1 |
| Chen, Y; Jian, Z; Li, H; Liao, B; Liu, Q; Wang, K; Yang, T | 1 |
| Haga, K; Hirose, T; Ichihara, K; Iwasawa, A; Masumori, N; Miyao, N; Nishimura, M; Sasamura, H; Suzuki, N; Taguchi, K; Yamaguchi, Y | 1 |
| Choi, WS; Son, H | 1 |
| Alcántara, A; Cózar, JM; Duran, A; Errando, C; Mora, AM; Rubio-Rodríguez, D; Rubio-Terrés, C | 1 |
| Dahm, P; Gandhi, S; Hwang, EC; Imamura, M; Jung, JH; Kim, MH; Pang, R | 1 |
| Dai, Y; Jiann, BP; Li, H; Li, P; Lou, Y; Park, HJ; Viktrup, L; Ye, Z; Zhang, X; Zhang, Z | 1 |
| Kitta, T | 1 |
| Bae, JH; Choi, H; Kim, JH; Kwon, SS; Park, JY; Shim, JS | 1 |
| Krishnappa, P; Moncada, I | 1 |
| Bi, J; Jiang, Y; Lin, Y; Wei, N; Xue, Z | 1 |
| Kuo, HC; Lee, CL | 1 |
| Bhatia, S; Clode, H; Sullivan, T | 1 |
| De Wachter, S; Foley, S; Huang, M; Rees, J; Rosa Arias, J; Skoumal, R; Walters, C; Yavuz, Y | 1 |
| Abou-Ramadan, AR; El-Abd, AS; El-Abd, SA; El-Sakka, AA; El-Tatawy, HH; Soliman, MG | 1 |
| Miernik, A; Praus, F | 1 |
| Alyaev, YG; Demidko, YL; Fiev, DN; Glybochko, PV; Kopylov, PY; Rapoport, LM; Syrkin, AL; Tsarichenko, DG; Vinarov, AZ | 1 |
| Angulo, JC; Garcia-Hernandez, A; Haab, F; Katona, F; Klaver, M; Oelke, M; Traudtner, K; Van Kerrebroeck, P; Vik, V | 2 |
| Apostolidis, A | 1 |
| Chapple, C; Drake, MJ; Drogendijk, T; Klaver, M; Sokol, R; Speakman, M; Traudtner, K; van Kerrebroeck, P | 1 |
| Araki, M; Araki, T; Monden, K | 1 |
| Mandal, AK; Mete, UK; Singh, DV; Singh, SK | 1 |
| Filson, CP; Hollingsworth, JM; Wei, JT | 1 |
| Baygani, SK; Giuliano, F; Melby, T; Oelke, M; Sontag, A | 1 |
| Carini, M; Corona, G; Ficarra, V; Gacci, M; Maggi, M; Novara, G; Sebastianelli, A; Serni, S; Shariat, SF; Zattoni, F | 1 |
| Choo, SH; Han, DH; Kim, JJ; Lee, SW; Sung, HH | 1 |
| Castro, R; D'Ancona, C; Manyak, M; Oelke, M; Roehrborn, CG; Wilson, TH | 1 |
| Choi, HS; Kim, SO; Kwon, D | 1 |
| Chapple, C; Drake, MJ; Drogendijk, T; Klaver, M; Oelke, M; Sokol, R; Traudtner, K; Van Kerrebroeck, P | 1 |
| Chang, PL; Chen, CL; Hou, CP; Juang, HH; Lin, YH; Tsai, YL; Tsui, KH | 1 |
| Choi, H; Doo, SW; Kim, JH; Kim, JM; Kwon, SS; Lee, HJ; Lim, IS; Song, ES; Song, YS; Sun, HY; Yang, WJ; Yoo, BW; Yoon, JH | 1 |
| Allegro, R; Arnone, S; Blefari, F; Carini, M; Cimino, S; Collura, Z; Fragalà, E; Gentile, M; Giannantoni, A; Ginepri, A; Minervini, A; Morgia, G; Palmieri, F; Pareo, RM; Russo, GI; Salvia, G; Santelli, G; Vespasiani, G; Voce, S | 1 |
| Doo, SW; Kim, JH; Lee, SW; Yang, HJ; Yang, WJ; Yun, JH | 1 |
| Hyun, JS; Kim, SW; Ko, K; Lee, SW; Lee, WK; Moon, du G; Moon, KH; Park, JK; Park, K; Park, NC; Son, HC; Yang, DY | 1 |
| Blak, B; Hakimi, Z; Johnson, M; Nazir, J; Odeyemi, IA | 1 |
| Bae, JH; Bae, MY; Choi, H; Hwang, SD; Kim, HJ; Kim, JH; Kim, KH; Lee, WJ; Shim, SR; Yoon, SJ | 1 |
| Crosby, RD; Drogendijk, T; Hakimi, Z; Klaver, M; Mathias, SD; Nazir, J; Odeyemi, IA | 1 |
| Altay, AB; Apaydin, E; Bademkiran, F; Cikili, N; Semerci, MB; Turna, B; Umul, M | 1 |
| De Nunzio, C; Tubaro, A | 1 |
| Drake, MJ; Pandian, S; Romancik, M | 1 |
| Ahn, SH; Choi, JD; Kim, JH; Lim, SW; Ryu, YW | 1 |
| Chung, SJ; Hwang, EC; Jung, SI; Kim, JW; Kwon, DD; Park, K; Ryu, JW | 1 |
| Dimitropoulos, K; Gravas, S | 1 |
| Coyne, K; Dorey, J; Drake, MJ; Hakimi, Z; Klaver, M; Nazir, J; Odeyemi, IA; Oelke, M; Sokol, R; Traudtner, K; van Kerrebroeck, P | 1 |
| Bae, JH; Choi, H; Park, JY; Sim, JS | 1 |
| Pahari, H; Shaw, MK | 1 |
| Hakimi, Z; Heemstra, L; Ivanescu, C; Nazir, J; van Engen, A | 1 |
| Aikawa, K; Akaihata, H; Hata, J; Kataoka, M; Kobayashi, T; Koguchi, T; Kojima, Y; Ogawa, S; Sato, Y; Shiragasawa, C; Yabe, M; Yamaguchi, O | 1 |
| Deng, D; Dong, W; Gong, M; Gong, Z; Huang, G; Qiu, S; Yuan, R | 1 |
| de la Taille, A; Latil, A; Pétrissans, MT; Robert, G; Rouquet, J | 1 |
| Angulo, JC | 1 |
| Jang, EY; Kim, KS; Kim, YT; Moon, HS | 1 |
| Cho, ST; Han, DH; Lee, YS; Yoon, H; Yoon, HS | 2 |
| Ahmed, AF | 1 |
| Arai, Y; Chiba, K; Horiuchi, S; Moriyama, S; Noro, A; Saito, K; Takeshita, H; Washino, S | 1 |
| Nieder, AM | 1 |
| Alcaraz, A; Baena-González, V; Brenes-Bermúdez, FJ; Carballido-Rodríguez, J; Cózar-Olmo, JM; García-Rojo, D; Manasanch, J; Medina-López, R; Rodríguez-Rubio, F; Ruiz-Cerdá, JL; Unda-Urzaiz, M | 1 |
| Boone, TB; Chan, R; Miles, B; Munoz, A; Wenker, EP; Whipple, M | 1 |
| Choi, CI; Kang, MH; Oh, JJ; Park, DS; Shin, HS; Yu, YD | 1 |
| Brotherton, B; Calomfirescu, N; Manyak, MJ; Oyarzabal Perez, I; Palacios, JM; Roehrborn, CG; Roos, EP; Vasylyev, A | 1 |
| Choi, IS; Park, JK; Shin, YS; You, JH; Zhang, LT; Zhao, C | 1 |
| Fallah-Karkan, M; Hassanzadeh-Hadad, A; Karami, H | 1 |
| Bongaerts, D; Drake, MJ; Klaver, M; Oelke, M; Snijder, R; Traudtner, K; van Charldorp, K; Van Kerrebroeck, P | 1 |
| Brassetti, A; De Nunzio, C; Esperto, F; Gacci, M; Proietti, F; Serni, S; Tubaro, A | 1 |
| Cheng, CL; Cheng, HL; Chiang, PH; Lin, AT; Tsui, KH; Wu, HC; Wu, TT; Yang, SS; Yu, HJ | 1 |
| Baba, S; Fujita, T; Hayakawa, K; Ishiyama, H; Kimura, M; Kitano, M; Kotani, S; Matsumoto, K; Minamida, S; Satoh, T; Tabata, K; Tsumura, H | 1 |
| Chung, BH; Chung, MS; Lee, SH; Park, KK; Yoo, SJ | 1 |
| Cox, D; Giuliano, F; Mirone, V; Oelke, M; Viktrup, L; Xu, L | 1 |
| Chapple, CR | 1 |
| Carini, M; Gacci, M; Lapini, A; Maggi, M; Rossetti, MA; Serni, S; Siena, G; Tosi, N; Vignozzi, L; Vittori, G | 1 |
| Hashida, I; Hosaka, N; Iijima, K; Kamigaito, T; Nishizawa, S; Okaneya, T; Yamagishi, T | 1 |
| Cummings, J; Fakhoury, A; He, W; Kaplan, SA; Koltun, WD; Schneider, T | 1 |
| Imaoka, T; Kim, SC; Morisaki, Y; Viktrup, L; Wang, CJ; Yokoyama, O; Yoshida, M | 1 |
| Gacci, M | 1 |
| Andersson, KE; Gratzke, C | 1 |
| Brown, JN; Meyer, LE | 1 |
| Artibani, W; Chapple, CR; Montorsi, F; Novara, G; Sanseverino, R; Spatafora, S; Tubaro, A; Zattoni, F | 1 |
| Lee, LM; Lin, KH; Lin, YW; Wen, YC | 1 |
| Bae, JH; Kim, JH; Kwon, SS; Lee, JG; Oh, MM; Park, JY | 1 |
| Andreadakis, S; Konstantinidis, C; Samarinas, M; Skriapas, K; Xanthis, S | 1 |
| Ding, H; Du, W; Hou, ZZ; Wang, HZ; Wang, ZP | 1 |
| Matthies, AK; Tachikawa, NJ | 1 |
| Botoca, M; Bucuras, V; Cumpanas, AA; Minciu, R | 1 |
22 review(s) available for tamsulosin and Lower Urinary Tract Symptom
| Article | Year |
|---|---|
Medical Treatment of Benign Prostatic Hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Tamsulosin | 2022 |
Tamsulosin Monotherapy Is Effective in Reducing Ureteral Stent-related Symptoms: A Meta-analysis of Randomized Controlled Studies.
Topics: Adrenergic alpha-1 Receptor Antagonists; Drug Therapy, Combination; Female; Humans; Lower Urinary Tract Symptoms; Male; Randomized Controlled Trials as Topic; Solifenacin Succinate; Stents; Tamsulosin; Treatment Outcome; Ureteral Diseases; Urological Agents | 2019 |
Defining the Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors with Tamsulosin for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia with or without Erectile Dysfunction: A Network Meta-Analysis.
Topics: Bayes Theorem; Databases, Factual; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Network Meta-Analysis; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Safety; Sildenafil Citrate; Tadalafil; Tamsulosin; Treatment Outcome | 2020 |
Comparative Effectiveness of Tadalafil versus Tamsulosin in Treating Lower Urinary Tract Symptoms Suggestive of Benign Prostate Hyperplasia: A Meta-Analysis of Randomized Controlled Trials.
Topics: Adrenergic alpha-1 Receptor Antagonists; Double-Blind Method; Drug Therapy, Combination; Humans; Hyperplasia; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Quality of Life; Randomized Controlled Trials as Topic; Tadalafil; Tamsulosin; Treatment Outcome | 2020 |
Tadalafil Alone or in Combination with Tamsulosin for the Management for LUTS/BPH and ED.
Topics: Combined Modality Therapy; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Tadalafil; Tamsulosin; Treatment Outcome; Urological Agents | 2020 |
Outcomes and complications of naftopidil versus tamsulosin for elderly men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: A systematic review and meta-analysis.
Topics: Aged; Humans; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome | 2021 |
Efficacy and tolerability of doxazosin gastro-intestinal therapeutic system versus tamsulosin in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: A systematic review and meta-analysis.
Topics: Doxazosin; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Tamsulosin; Treatment Outcome; Urological Agents | 2021 |
Tamsulosin for treatment of lower urinary tract symptoms in women: a systematic review and meta-analysis.
Topics: Female; Humans; Lower Urinary Tract Symptoms; Sulfonamides; Tamsulosin; Treatment Outcome; Urological Agents | 2017 |
The role of solifenacin, as monotherapy or combination with tamsulosin in ureteral stent-related symptoms: a systematic review and meta-analysis.
Topics: Adrenergic alpha-1 Receptor Antagonists; Drug Therapy, Combination; Flank Pain; Health Status; Hematuria; Humans; Lower Urinary Tract Symptoms; Muscarinic Antagonists; Postoperative Complications; Quality of Life; Solifenacin Succinate; Stents; Sulfonamides; Tamsulosin; Ureter; Xerostomia | 2017 |
Is Tamsulosin Linked to Dementia in the Elderly?
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Brain; Cognition; Dementia; Humans; Lower Urinary Tract Symptoms; Sulfonamides; Tamsulosin; Urological Agents | 2018 |
Combination of solifenacin and tamsulosin may provide additional beneficial effects for ureteral stent-related symptoms-outcomes from a network meta-analysis.
Topics: Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Network Meta-Analysis; Pain; Quinazolines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Stents; Tamsulosin; Treatment Outcome; Urinary Catheterization; Urological Agents | 2019 |
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Benzilates; Drug Combinations; Ethamsylate; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Plant Extracts; Prostatic Hyperplasia; Prostatism; Quality of Life; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Urological Agents | 2018 |
[LUTS in BPH patients : Comparison of silodosin versus tamsulosin, naftopidil, alfuzosin and placebo for the treatment of lower urinary tract symptoms].
Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quinazolines; Tamsulosin; Treatment Outcome; Urological Agents | 2019 |
Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis.
Topics: Adrenergic alpha-1 Receptor Antagonists; Azasteroids; Doxazosin; Dutasteride; Ejaculation; Finasteride; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Sulfonamides; Tamsulosin; Urological Agents | 2014 |
General effect of low-dose tamsulosin (0.2 mg) as a first-line treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia: a systematic review and meta-analysis.
Topics: Asia; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Quality of Life; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Treatment Outcome; Urological Agents | 2015 |
Benign prostatic hyperplasia in 2014: Innovations in medical and surgical treatment.
Topics: Acetylcholine Release Inhibitors; Botulinum Toxins, Type A; Drug Combinations; Humans; Laser Therapy; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Prostatism; Solifenacin Succinate; Sulfonamides; Tadalafil; Tamsulosin; Transurethral Resection of Prostate; Urological Agents | 2015 |
Tamsulosin/solifenacin fixed-dose combination tablet for the treatment of male lower urinary tract symptoms.
Topics: Clinical Trials as Topic; Drug Combinations; Humans; Lower Urinary Tract Symptoms; Male; Solifenacin Succinate; Sulfonamides; Tablets; Tamsulosin; Urological Agents | 2014 |
Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia.
Topics: Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tamsulosin | 2015 |
Tamsulosin combined with solifenacin versus tamsulosin monotherapy for male lower urinary tract symptoms: a meta-analysis.
Topics: Drug Monitoring; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Outcome Assessment, Health Care; Prostatic Hyperplasia; Quality of Life; Solifenacin Succinate; Sulfonamides; Tamsulosin; Urinary Retention; Urological Agents | 2015 |
Tamsulosin for voiding dysfunction in women.
Topics: Adrenergic alpha-1 Receptor Antagonists; Female; Humans; Lower Urinary Tract Symptoms; Sulfonamides; Tamsulosin; Urination Disorders | 2012 |
Systematic review and meta-analysis of randomized controlled trials evaluating silodosin in the treatment of non-neurogenic male lower urinary tract symptoms suggestive of benign prostatic enlargement.
Topics: Dose-Response Relationship, Drug; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Treatment Outcome; Urological Agents | 2013 |
Silodosin is effective for treatment of LUTS in men with BPH: a systematic review.
Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin | 2013 |
55 trial(s) available for tamsulosin and Lower Urinary Tract Symptom
| Article | Year |
|---|---|
Combination therapy with tamsulosin and traditional herbal medicine for lower urinary tract symptoms due to benign prostatic hyperplasia: A double-blinded, randomized, pilot clinical trial.
Topics: Double-Blind Method; Drug Therapy, Combination; Herbal Medicine; Humans; Lower Urinary Tract Symptoms; Male; Pain; Prospective Studies; Prostatic Hyperplasia; Prostatitis; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome | 2022 |
Editorial Comment to Combination therapy with tamsulosin and traditional herbal medicine for lower urinary tract symptoms due to benign prostatic hyperplasia: A double-blinded, randomized, pilot clinical trial.
Topics: Double-Blind Method; Drug Therapy, Combination; Herbal Medicine; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Tadalafil; Tamsulosin; Treatment Outcome | 2022 |
Influence of alpha-adrenoceptor antagonists therapy on stool form in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Defecation; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Surveys and Questionnaires; Symptom Assessment; Tamsulosin; Treatment Outcome | 2020 |
Add-on effects of tadalafil in tamsulosin-treated patients with small benign prostatic enlargement: A randomized, placebo-controlled, double-blind, crossover study.
Topics: Aged; Aged, 80 and over; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Quality of Life; Tadalafil; Tamsulosin; Treatment Outcome; Urological Agents | 2020 |
Mirabegron Add-on Therapy to Tamsulosin for the Treatment of Overactive Bladder in Men with Lower Urinary Tract Symptoms: A Randomized, Placebo-controlled Study (MATCH).
Topics: Acetanilides; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-3 Receptor Agonists; Aged; Double-Blind Method; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Single-Blind Method; Tamsulosin; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive | 2020 |
Men's Sexual Health Questionnaire score changes vs spontaneous sexual adverse event reporting in men treated with dutasteride/tamsulosin combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A post hoc analysis of
Topics: Aged; Double-Blind Method; Dutasteride; Ejaculation; Humans; Libido; Lower Urinary Tract Symptoms; Male; Men's Health; Middle Aged; Penile Erection; Prospective Studies; Prostatic Hyperplasia; Sexual Behavior; Sexual Health; Surveys and Questionnaires; Tamsulosin | 2020 |
[Therapeutic effect of tadalafil on lower urinary tract symptoms with erectile dysfunction].
Topics: Carbolines; Double-Blind Method; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Tadalafil; Tamsulosin; Treatment Outcome | 2019 |
Does tamsulosin or mirabegron improve ureteral stent-related symptoms? A prospective placebo-controlled study.
Topics: Acetanilides; Adult; Female; Humans; Lithotripsy; Lower Urinary Tract Symptoms; Male; Middle Aged; Stents; Surveys and Questionnaires; Tamsulosin; Thiazoles; Ureter; Urological Agents | 2021 |
Efficacy and safety of tadalafil vs tamsulosin in lower urinary tract symptoms (LUTS) as a result of benign prostate hyperplasia (BPH)-open label randomised controlled study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Double-Blind Method; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Quality of Life; Tadalafil; Tamsulosin; Treatment Outcome; Urological Agents | 2020 |
Cardiovascular safety of mirabegron add-on therapy to tamsulosin for the treatment of overactive bladder in men with lower urinary tract symptoms: A post hoc analysis from the MATCH study.
Topics: Acetanilides; Age Factors; Aged; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Tamsulosin; Thiazoles; Urinary Bladder, Overactive | 2021 |
Mirabegron Vs Placebo Add-on Therapy in Men With Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Safety Analysis From the Randomized, Phase 4 PLUS Study.
Topics: Acetanilides; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-3 Receptor Agonists; Adult; Aged; Double-Blind Method; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Tamsulosin; Thiazoles; Urinary Bladder, Overactive | 2021 |
Combination therapy with omega-3 fatty acids plus tamsulocin and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH).
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Drug Therapy, Combination; Fatty Acids, Omega-3; Finasteride; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Single-Blind Method; Sulfonamides; Tamsulosin; Treatment Outcome; Urological Agents | 2017 |
Clinical evaluation of tamsulosin in the relief of lower urinary tract symptoms in advanced prostate cancer patients.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Antineoplastic Combined Chemotherapy Protocols; Flutamide; Goserelin; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Neoplasms; Quality of Life; Severity of Illness Index; Sulfonamides; Tamsulosin; Time Factors; Urodynamics | 2017 |
Does combination therapy with tamsulosin and trospium chloride improve lower urinary tract symptoms after SEEDS brachytherapy for prostate cancer compared with tamsulosin alone? : A prospective, randomized, controlled trial.
Topics: Aged; Benzilates; Brachytherapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Nortropanes; Prospective Studies; Prostatic Neoplasms; Quality of Life; Radiation Injuries; Sulfonamides; Tamsulosin; Urodynamics | 2017 |
Efficacy and Safety of a Fixed-Dose Combination Therapy of Tamsulosin and Tadalafil for Patients With Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Randomized, Double-Blinded, Active-Controlled Trial.
Topics: Aged; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Urological Agents | 2017 |
[Efficacy of tamsulosin for treating lower urinary tract symptoms in patients with advanced prostate cancer].
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Androgen Antagonists; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Neoplasms; Sulfonamides; Tamsulosin | 2017 |
A prospective randomised placebo-controlled study of the impact of dutasteride/tamsulosin combination therapy on sexual function domains in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).
Topics: Aged; Aged, 80 and over; Dutasteride; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Satisfaction; Penile Erection; Placebos; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urological Agents | 2018 |
Role of silodosin in patients with LUTS/BPE non responding to medical treatment with tamsulosin: a prospective, open-label, pilot study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Middle Aged; Pilot Projects; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome | 2017 |
An open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with tre
Topics: Administration, Oral; Aged; Aged, 80 and over; Drug Tolerance; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Satisfaction; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome; Urination; Urological Agents | 2018 |
Efficacy and safety of tamsulosin 0.4 mg single pills for treatment of Asian patients with symptomatic benign prostatic hyperplasia with lower urinary tract symptoms: a randomized, double-blind, phase 3 trial.
Topics: Aged; Asian People; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Republic of Korea; Tamsulosin; Treatment Outcome; Urological Agents | 2018 |
Efficacy and safety of tadalafil 5 mg once-daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double-blind, parallel, placebo- and tamsulosin-controlled s
Topics: Aged; China; Double-Blind Method; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Placebos; Prostatic Hyperplasia; Republic of Korea; Severity of Illness Index; Tadalafil; Taiwan; Tamsulosin; Treatment Outcome | 2019 |
The evaluation of nocturia in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and the analysis of the curative effect after medical or placebo therapy for nocturia: a randomized placebo-controlled study.
Topics: Aged; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Nocturia; Placebo Effect; Prostatic Hyperplasia; Tamsulosin; Treatment Outcome; Urological Agents | 2018 |
Management of Male Lower Urinary Tract Symptoms in a Simulated, Over-the-Counter Setting: An Exploratory Study of Tamsulosin.
Topics: Adult; Health Behavior; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Nonprescription Drugs; Prostatic Hyperplasia; Quality of Life; Tamsulosin; Treatment Outcome; Urological Agents | 2019 |
Outcome of Modification of Dose and Time of Administration of Tamsulosin in Men with Abnormal Ejaculation.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Drug Administration Schedule; Ejaculation; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Pelvic Pain; Prospective Studies; Prostatitis; Quality of Life; Sexual Dysfunction, Physiological; Tamsulosin; Treatment Outcome | 2019 |
Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage lower urinary tract symptoms: results from a phase 2, dose-finding study (SATURN).
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug Dosage Calculations; Drug Therapy, Combination; Europe; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Muscarinic Antagonists; Quality of Life; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Time Factors; Treatment Outcome; Urinary Bladder; Urination; Urination Disorders; Urodynamics; Urological Agents | 2013 |
Combination therapy with solifenacin and tamsulosin oral controlled absorption system in a single tablet for lower urinary tract symptoms in men: efficacy and safety results from the randomised controlled NEPTUNE trial.
Topics: Absorption; Administration, Oral; Adrenergic alpha-1 Receptor Antagonists; Aged; Double-Blind Method; Drug Combinations; Humans; Lower Urinary Tract Symptoms; Male; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tablets; Tamsulosin; Tetrahydroisoquinolines | 2013 |
Comparison of 7 α(1)-adrenoceptor antagonists in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia:a short-term crossover study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Cross-Over Studies; Doxazosin; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Middle Aged; Naphthalenes; Piperazines; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome | 2013 |
A comparative randomized prospective study to evaluate efficacy and safety of combination of tamsulosin and tadalafil vs. tamsulosin or tadalafil alone in patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Carbolines; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Prospective Studies; Prostatic Hyperplasia; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Urinary Retention | 2014 |
Treatment satisfaction with tadalafil or tamsulosin vs placebo in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH): results from a randomised, placebo-controlled study.
Topics: Aged; Aged, 80 and over; Carbolines; Double-Blind Method; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Satisfaction; Prostatic Hyperplasia; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Urological Agents | 2014 |
Efficacy and tolerability of tamsulosin 0.4 mg in Asian patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia refractory to tamsulosin 0.2 mg: a randomized placebo controlled trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Asian People; Cardiovascular Diseases; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Placebos; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urination | 2014 |
Nocturia improvement in the combination of Avodart(®) and tamsulosin (CombAT) study.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Aged; Azasteroids; Double-Blind Method; Drug Combinations; Dutasteride; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Nocturia; Prostatic Hyperplasia; Sulfonamides; Tamsulosin | 2014 |
Long-term safety and efficacy of single-tablet combinations of solifenacin and tamsulosin oral controlled absorption system in men with storage and voiding lower urinary tract symptoms: results from the NEPTUNE Study and NEPTUNE II open-label extension.
Topics: Administration, Oral; Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Chemistry, Pharmaceutical; Double-Blind Method; Drug Combinations; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Muscarinic Antagonists; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tablets; Tamsulosin; Time Factors; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urinary Retention; Urodynamics; Urological Agents | 2015 |
Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double-blinded randomized study between single or combination therapy (PROCOMB trial).
Topics: Aged; Aged, 80 and over; Antioxidants; Carotenoids; Double-Blind Method; Drug Therapy, Combination; Humans; Italy; Lower Urinary Tract Symptoms; Lycopene; Male; Middle Aged; Phytotherapy; Prostatic Hyperplasia; Quality of Life; Selenium; Serenoa; Sulfonamides; Tamsulosin; Treatment Outcome; Urodynamics; Urological Agents | 2014 |
Can we decide the optimal initial treatment for male lower urinary tract symptoms patients with overactive bladder by the most bothersome symptom? A randomized, prospective, open-label study.
Topics: Aged; Decision Making; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Prostate; Quality of Life; Quinuclidines; Republic of Korea; Solifenacin Succinate; Sulfonamides; Symptom Assessment; Tamsulosin; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urination | 2014 |
Effect of improvement in lower urinary tract symptoms on sexual function in men: tamsulosin monotherapy vs. combination therapy of tamsulosin and solifenacin.
Topics: Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Quality of Life; Quinuclidines; Rheology; Solifenacin Succinate; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Tetrahydroisoquinolines; Treatment Outcome; Urological Agents | 2014 |
Validation of the Patient Perception of Intensity of Urgency Scale in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Psychometrics; Quinuclidines; Reproducibility of Results; Severity of Illness Index; Solifenacin Succinate; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Tetrahydroisoquinolines; Urological Agents | 2014 |
Comparison of tamsulosin plus serenoa repens with tamsulosin in the treatment of benign prostatic hyperplasia in Korean men: 1-year randomized open label study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Asian People; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Plant Extracts; Prostatic Hyperplasia; Republic of Korea; Serenoa; Sulfonamides; Tamsulosin; Time Factors; Treatment Outcome; Urinary Bladder; Urodynamics; Urological Agents | 2015 |
The preventive effect of tamsulosin on voiding dysfunction after prostate biopsy: a prospective, open-label, observational study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Prostate; Sulfonamides; Tamsulosin; Urinary Retention; Urodynamics | 2015 |
Responder and health-related quality of life analyses in men with lower urinary tract symptoms treated with a fixed-dose combination of solifenacin and tamsulosin oral-controlled absorption system: results from the NEPTUNE study.
Topics: Double-Blind Method; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Quality of Life; Solifenacin Succinate; Sulfonamides; Tamsulosin; Urological Agents | 2016 |
The role of peri-operative use of alpha-blocker in preventing lower urinary tract symptoms in high risk patients of urinary retention undergoing inguinal hernia repair in males above 50 years.
Topics: Adrenergic alpha-Antagonists; Age Factors; Aged; Double-Blind Method; Hernia, Inguinal; Herniorrhaphy; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Perioperative Care; Prevalence; Prospective Studies; Sulfonamides; Tamsulosin; Urinary Retention | 2014 |
Effects of hexanic extract of Serenoa repens (Permixon® 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia.
Topics: Aged; Androgen Antagonists; Biomarkers; Double-Blind Method; Humans; Inflammation; Lower Urinary Tract Symptoms; Male; Middle Aged; Plant Extracts; Prostatic Hyperplasia; Serenoa; Sulfonamides; Tamsulosin; Treatment Outcome | 2015 |
Effect of Tamsulosin in Lower Urinary Tract Symptom Patients With Metabolic Syndrome.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Female; Humans; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Sulfonamides; Tamsulosin; Treatment Outcome | 2016 |
Randomized Crossover Comparison of the Short-Term Efficacy and Safety of Single Half-Dose Silodosin and Tamsulosin Hydrochoride in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Cross-Over Studies; Drug Therapy, Combination; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Time Factors; Treatment Outcome | 2016 |
Efficacy and safety of tamsulosin hydrochloride 0.2 mg and combination of tamsulosin hydrochloride 0.2 mg plus solifenacin succinate 5 mg after transurethral resection of the prostate: a prospective, randomized controlled trial.
Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Quality of Life; Solifenacin Succinate; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents | 2016 |
Comparing Monotherapy with Tadalafil or Tamsulosin and Their Combination Therapy in Men with Benign Prostatic Hyperplasia: A Randomized Clinical Trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Single-Blind Method; Sulfonamides; Tadalafil; Tamsulosin | 2016 |
Incidence of urinary retention during treatment with single tablet combinations of solifenacin+tamsulosin OCAS™ for up to 1 year in adult men with both storage and voiding LUTS: A subanalysis of the NEPTUNE/NEPTUNE II randomized controlled studies.
Topics: Drug Combinations; Humans; Incidence; Lower Urinary Tract Symptoms; Male; Risk Factors; Solifenacin Succinate; Sulfonamides; Tablets; Tamsulosin; Time Factors; Urinary Retention; Urological Agents | 2017 |
Non-inferiority of silodosin to tamsulosin in treating patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Blood Pressure; Double-Blind Method; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urodynamics | 2011 |
Comparison of prophylactic naftopidil, tamsulosin, and silodosin for 125I brachytherapy-induced lower urinary tract symptoms in patients with prostate cancer: randomized controlled trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Analysis of Variance; Brachytherapy; Humans; Indoles; Iodine Radioisotopes; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Prostatic Neoplasms; Quality of Life; Radiotherapy Dosage; Sulfonamides; Tamsulosin | 2011 |
Comparative rapid onset of efficacy between doxazosin gastrointestinal therapeutic system and tamsulosin in patients with lower urinary tract symptoms from benign prostatic hyperplasia: a multicentre, prospective, randomised study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome | 2011 |
Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Carbolines; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Satisfaction; Prostatic Hyperplasia; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Vasodilator Agents | 2012 |
A randomized, placebo-controlled study to assess safety and efficacy of vardenafil 10 mg and tamsulosin 0.4 mg vs. tamsulosin 0.4 mg alone in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Imidazoles; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Piperazines; Prostatic Hyperplasia; Sulfonamides; Sulfones; Tamsulosin; Triazines; Vardenafil Dihydrochloride | 2012 |
Solifenacin plus tamsulosin combination treatment in men with lower urinary tract symptoms and bladder outlet obstruction: a randomized controlled trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Analysis of Variance; Double-Blind Method; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Muscarinic Antagonists; Pressure; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Time Factors; Treatment Outcome; Urinary Bladder; Urinary Bladder Neck Obstruction; Urodynamics | 2013 |
Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized placebo- and tamsulosin-controlled 12-week study in Asian men.
Topics: Administration, Oral; Aged; Analysis of Variance; Carbolines; Double-Blind Method; Drug Administration Schedule; Follow-Up Studies; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Selection; Phosphodiesterase 5 Inhibitors; Prospective Studies; Prostatic Hyperplasia; Reference Values; Risk Assessment; Severity of Illness Index; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Urination; Urodynamics | 2013 |
Treatment satisfaction with low-dose tamsulosin for symptomatic benign prostatic hyperplasia: results from a multicentre cross-sectional survey.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Cross-Sectional Studies; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Satisfaction; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urination | 2012 |
Lower urinary tract symptoms associated with benign prostatic hyperplasia: combined treatment with fesoterodine fumarate extended-release and tamsulosin--a prospective study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Benzhydryl Compounds; Cholinergic Antagonists; Delayed-Action Preparations; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urinary Tract | 2013 |
55 other study(ies) available for tamsulosin and Lower Urinary Tract Symptom
| Article | Year |
|---|---|
Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients.
Topics: Female; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Phytotherapy; Plant Extracts; Prostatic Hyperplasia; Quality of Life; Serenoa; Tamsulosin; Treatment Outcome | 2021 |
Drug Prescription Patterns During Initial Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Study Based on Health Insurance Review and Assessment Database.
Topics: Adult; Drug Prescriptions; Humans; Insurance, Health; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Tamsulosin | 2022 |
Understanding Treatment Response in Individual Profiles of Men with Prostatic Enlargement at Risk of Progression.
Topics: Azasteroids; Disease Progression; Drug Therapy, Combination; Dutasteride; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Retention | 2023 |
[Molecular genetic predictors of the efficacy and safety of tamsulosin therapy].
Topics: Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Molecular Biology; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome | 2022 |
Is Dipstick Urinalysis Screening Beneficial in Men with Lower Urinary Tract Symptoms?
Topics: Adult; Aged; Aged, 80 and over; Humans; Lower Urinary Tract Symptoms; Male; Mass Screening; Middle Aged; Self Care; Tamsulosin; Urinalysis; Urological Agents | 2019 |
Characteristics of men with untreated LUTS interested in over-the-counter tamsulosin.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Nonprescription Drugs; Patient Satisfaction; Pilot Projects; Prospective Studies; Prostatic Hyperplasia; Risk Assessment; Self-Management; Tamsulosin; Treatment Outcome; United States; Urinary Retention | 2019 |
Which Drug to Discontinue 3 Months After Combination Therapy of Tadalafil plus Tamsulosin for Men with Lower Urinary Tract Symptom and Erectile Dysfunction? Results of a Prospective Observational Trial.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Tadalafil; Tamsulosin; Urological Agents | 2021 |
Re: Management of Male Lower Urinary Tract Symptoms in a Simulated, Over-the-Counter Setting: An Exploratory Study of Tamsulosin.
Topics: Humans; Lower Urinary Tract Symptoms; Male; Tamsulosin; Urinary Bladder; Urological Agents | 2019 |
Tamsulosin plus a new complementary and alternative medicine in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: Results from a retrospective comparative study.
Topics: Aged; Combined Modality Therapy; Complementary Therapies; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Retrospective Studies; Tamsulosin; Treatment Outcome; Urological Agents | 2020 |
Outcomes of combination therapy with daily tadalafil 5 mg plus tamsulosin 0.4 mg to treat lower urinary tract symptoms and erectile dysfunction in men with or without metabolic syndrome.
Topics: Double-Blind Method; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Quality of Life; Tadalafil; Tamsulosin | 2021 |
Impact of early vs. delayed initiation of dutasteride/tamsulosin combination therapy on the risk of acute urinary retention or BPH-related surgery in LUTS/BPH patients with moderate-to-severe symptoms at risk of disease progression.
Topics: 5-alpha Reductase Inhibitors; Acute Disease; Adrenergic alpha-1 Receptor Antagonists; Disease Progression; Drug Combinations; Dutasteride; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Risk Assessment; Severity of Illness Index; Symptom Assessment; Tamsulosin; Time Factors; Urinary Retention | 2021 |
[Patient Background Factors Affecting Prescription Drugs for Male Lower Urinary Tract Symptoms: The Multicenter Study of Miyazaki Urological-Network Group].
Topics: Aged; Humans; Lower Urinary Tract Symptoms; Male; Prescription Drugs; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome | 2020 |
Primary Treatment for Prostate Cancer in an Elderly Man.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged, 80 and over; Digital Rectal Examination; Humans; Lower Urinary Tract Symptoms; Male; Neoplasm Grading; Prostate-Specific Antigen; Prostatic Neoplasms; Robotic Surgical Procedures; Tamsulosin; Treatment Outcome; Ultrasound, High-Intensity Focused, Transrectal | 2017 |
Re: Efficacy of Tamsulosin, Oxybutynin, and Their Combination in the Control of Double-J Stent-Related Lower Urinary Tract Symptoms.
Topics: Humans; Lower Urinary Tract Symptoms; Mandelic Acids; Stents; Tamsulosin | 2018 |
Silodosin as second-line α-blocker monotherapy in patients with benign prostatic hyperplasia: A prospective observational study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Severity of Illness Index; Tamsulosin; Treatment Outcome | 2018 |
The change of IPSS 7 (nocturia) score has the maximum influence on the change of Qol score in patients with lower urinary tract symptoms.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Nocturia; Quality of Life; Tamsulosin | 2019 |
[Cost-effectiveness model of a fixed dose combination of solifenacin and tamsulosin for the treatment of LUTS associated with BPH with inadequate response to monotherapy.]
Topics: Adrenergic alpha-1 Receptor Antagonists; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Markov Chains; Models, Economic; Muscarinic Antagonists; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tamsulosin; Treatment Outcome | 2018 |
Re: Efficacy and Safety of a Fixed-Dose Combination Therapy of Tamsulosin and Tadalafil for Patients with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Randomized, Double-Blinded, Active-Controlled Trial.
Topics: Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Tadalafil; Tamsulosin | 2018 |
Editorial Comment to Efficacy and safety of tadalafil 5 mg once-daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double-blind, parallel, placebo- and ta
Topics: Double-Blind Method; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Tadalafil; Tamsulosin | 2019 |
Who are suitable for low-dose tamsulosin monotherapy as initial treatment strategy in male patients with lower urinary tract symptoms?
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Cross-Sectional Studies; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Satisfaction; Prostatic Hyperplasia; Quality of Life; ROC Curve; Sulfonamides; Tamsulosin; Treatment Outcome; Urination | 2018 |
Re: A Prospective Randomised Placebo-controlled Study of the Impact of Dutasteride/Tamsulosin Combination Therapy on Sexual Function Domains in Sexually Active Men with Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH).
Topics: Dutasteride; Humans; Lower Urinary Tract Symptoms; Male; Prospective Studies; Prostatic Hyperplasia; Tamsulosin | 2019 |
Male patients with a higher frequency of nocturnal urinary episodes are more likely to benefit from alpha-blocker therapy for bothersome nocturia.
Topics: Adrenergic alpha-Antagonists; Aged; Humans; Lower Urinary Tract Symptoms; Male; Nocturia; Retrospective Studies; Severity of Illness Index; Tamsulosin; Treatment Outcome; Urodynamics | 2019 |
Prostatic Artery Embolization via Variant Unilateral Right Prostatic Artery.
Topics: Acrylic Resins; Adrenergic alpha-1 Receptor Antagonists; Angiography; Arteries; Embolization, Therapeutic; Gelatin; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Tamsulosin; Treatment Outcome | 2019 |
Vesomni improves the quality of life in men with lower urinary tract symptoms in routine clinical practice in Europe.
Topics: Adult; Aged; Aged, 80 and over; Drug Combinations; Europe; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Satisfaction; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Solifenacin Succinate; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents | 2019 |
Re: A Prospective Randomised Placebo-Controlled Study of the Impact of Dutasteride/Tamsulosin Combination Therapy on Sexual Function Domains in Sexually Active Men with Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH).
Topics: Dutasteride; Humans; Lower Urinary Tract Symptoms; Male; Prospective Studies; Prostatic Hyperplasia; Tamsulosin | 2019 |
Holter Monitoring (24-Hour ECG) Parameter Dynamics in Patients with Ischemic Heart Disease and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Electrocardiography, Ambulatory; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Myocardial Ischemia; Prostatic Hyperplasia; Russia; Tamsulosin; Urethral Obstruction; Urological Agents | 2019 |
Male lower urinary tract symptoms: a riddle waiting to be solved.
Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Lower Urinary Tract Symptoms; Male; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder; Urination Disorders; Urological Agents | 2013 |
Reply from authors re: Apostolos Apostolidis. Male lower urinary tract symptoms: a riddle waiting to be solved. Eur Urol 2013;64:408-10: a rationale for combination antimuscarinic-α-blocker therapy for male lower urinary tract symptoms.
Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Lower Urinary Tract Symptoms; Male; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder; Urination Disorders; Urological Agents | 2013 |
Trends in medical management of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Aged; Azasteroids; Cholinergic Antagonists; Disease Management; Drug Therapy, Combination; Dutasteride; Humans; Logistic Models; Lower Urinary Tract Symptoms; Male; Middle Aged; Practice Patterns, Physicians'; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urological Agents | 2013 |
The α1 adrenoceptor antagonist tamsulosin for the treatment of voiding symptoms improves nocturia and sleep quality in women.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Dyssomnias; Female; Humans; Lower Urinary Tract Symptoms; Middle Aged; Nocturia; Prospective Studies; Quality of Life; Severity of Illness Index; Sleep; Sulfonamides; Surveys and Questionnaires; Tamsulosin | 2014 |
Prostatic urethral angle might be a predictor of treatment efficacy of α-blockers in men with lower urinary tract symptoms.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cohort Studies; Databases, Factual; Humans; Linear Models; Lower Urinary Tract Symptoms; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Prostatic Hyperplasia; Severity of Illness Index; Sulfonamides; Tamsulosin; Treatment Outcome; Urethra; Urination | 2014 |
Measuring the improvement in health-related quality of life using King's health questionnaire in non-obese and obese patients with lower urinary tract symptoms after alpha-adrenergic medication: a preliminary study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Body Mass Index; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Obesity; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Waist Circumference | 2014 |
Drug treatment patterns for the management of men with lower urinary tract symptoms associated with benign prostatic hyperplasia who have both storage and voiding symptoms: a study using the health improvement network UK primary care data.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Benzhydryl Compounds; Cresols; Family Practice; Humans; Lower Urinary Tract Symptoms; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Primary Health Care; Prostatic Hyperplasia; Quinuclidines; Retrospective Studies; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Tolterodine Tartrate; United Kingdom | 2015 |
The relationship between lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: the role of autonomic hyperactivity.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Autonomic Nervous System; Blood Glucose; Body Mass Index; Erectile Dysfunction; Humans; Lipids; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Risk Factors; Sulfonamides; Tamsulosin; Testosterone | 2014 |
Assessment of Tamsulosin 0.2 mg for Symptomatic Bladder Outlet Obstruction Secondary to Benign Prostatic Enlargement: Data from a Korean Multicenter Cross-Sectional Study.
Topics: Aged; Aged, 80 and over; Cross-Sectional Studies; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Satisfaction; Prostatic Hyperplasia; Republic of Korea; Retrospective Studies; Risk Factors; Severity of Illness Index; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Treatment Outcome; Urinary Bladder Neck Obstruction; Urological Agents | 2015 |
Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
Topics: Administration, Oral; Aged; Aged, 80 and over; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Combinations; Drug Therapy, Combination; Follow-Up Studies; Humans; Lower Urinary Tract Symptoms; Male; Markov Chains; Middle Aged; Prostatic Hyperplasia; Severity of Illness Index; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Treatment Outcome; Urodynamics | 2015 |
Elucidation of the Pattern of the Onset of Male Lower Urinary Tract Symptoms Using Cluster Analysis: Efficacy of Tamsulosin in Each Symptom Group.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Cluster Analysis; Humans; Lower Urinary Tract Symptoms; Male; Prospective Studies; Sulfonamides; Tamsulosin; Treatment Outcome | 2015 |
Combination therapy with tamsulosin and solifenacin for male lower urinary tract symptoms with predominant filling symptoms: a new approach to an old problem.
Topics: Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Muscarinic Antagonists; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tamsulosin | 2015 |
Tamsulosin Treatment Affecting Patient-reported Outcomes in Benign Prostatic Hyperplasia-associated Depressive Symptoms.
Topics: Administration, Oral; Adrenergic alpha-1 Receptor Antagonists; Adult; Depression; Dose-Response Relationship, Drug; Endosonography; Follow-Up Studies; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Outcome Assessment; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Treatment Outcome; Urination | 2016 |
Sonographic Parameters Predicting the Outcome of Patients With Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Treated With Alpha1-Adrenoreceptor Antagonist.
Topics: Aged; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Treatment Outcome; Ultrasonography | 2016 |
Editorial Comment.
Topics: Adrenergic alpha-1 Receptor Antagonists; Female; Humans; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Sulfonamides; Tamsulosin | 2016 |
Author Reply.
Topics: Adrenergic alpha-1 Receptor Antagonists; Female; Humans; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Sulfonamides; Tamsulosin | 2016 |
Quality of life in patients with lower urinary tract symptoms associated with BPH: change over time in real-life practice according to treatment--the QUALIPROST study.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Drug Therapy, Combination; Dutasteride; Finasteride; Humans; Longitudinal Studies; Lower Urinary Tract Symptoms; Male; Middle Aged; Phytotherapy; Plant Extracts; Prospective Studies; Prostatic Hyperplasia; Prostatism; Quality of Life; Serenoa; Severity of Illness Index; Sulfonamides; Tamsulosin; Watchful Waiting | 2016 |
Solifenacin and Tamsulosin Combination Therapy Decreases Urine Nerve Growth Factor/Creatinine Levels in Men.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Creatinine; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Muscarinic Antagonists; Nerve Growth Factor; Pilot Projects; Solifenacin Succinate; Sulfonamides; Tamsulosin | 2016 |
Clinical efficacy of combination therapy with an alpha blocker and low-dose sildenafil on post-therapy lower urinary tract symptoms after low-dose-rate brachytherapy for prostate cancer.
Topics: Adrenergic alpha-Antagonists; Aged; Brachytherapy; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prospective Studies; Prostatic Neoplasms; Radiotherapy Dosage; Sildenafil Citrate; Sulfonamides; Tamsulosin; Treatment Outcome | 2016 |
Can we use baseline characteristics to assess which men with moderately symptomatic benign prostatic hyperplasia at risk of progression will benefit from treatment? A post hoc analysis of data from the 2-year CONDUCT study.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Aged; Disease Progression; Drug Therapy, Combination; Dutasteride; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Quality of Life; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Sulfonamides; Tamsulosin; Treatment Outcome; Watchful Waiting | 2017 |
Re: Long-Term Safety and Efficacy of Single-Tablet Combinations of Solifenacin and Tamsulosin Oral Controlled Absorption System in Men with Storage and Voiding Lower Urinary Tract Symptoms: Results from the NEPTUNE Study and NEPTUNE II Open-Label Extensio
Topics: Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Neptune; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tablets; Tamsulosin; Treatment Outcome | 2016 |
Dutasteride add-on therapy reduces detrusor mass in patients with benign prostatic enlargement not satisfied with alpha-adrenergic antagonist monotherapy: A single center prospective study.
Topics: Adrenergic alpha-Antagonists; Aged; Drug Therapy, Combination; Dutasteride; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Muscle, Smooth; Organ Size; Prospective Studies; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Ultrasonography; Urinary Bladder; Urinary Bladder Neck Obstruction; Urodynamics | 2017 |
Monotherapy with α-blocker or phosphodiesterase 5 inhibitor for lower urinary tract symptoms?
Topics: Adrenergic alpha-1 Receptor Antagonists; Carbolines; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Sulfonamides; Tadalafil; Tamsulosin; Vasodilator Agents | 2012 |
[Clinical evaluation of lower urinary tract symptoms following seed implant for prostate cancer].
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Brachytherapy; Humans; Iodine Radioisotopes; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Neoplasms; Quality of Life; Radiography; Sulfonamides; Tamsulosin | 2012 |
Editorial Comment to tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized placebo- and tamsulosin-controlled 12-week study in Asian men.
Topics: Carbolines; Humans; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Sulfonamides; Tadalafil; Tamsulosin | 2013 |
α-Blockers and antimuscarinics for male lower urinary tract symptoms: the search goes on.
Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Lower Urinary Tract Symptoms; Male; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder; Urinary Bladder Neck Obstruction | 2013 |
Efficacy and safety of orally disintegrating tamsulosin tablets in Taiwanese patients with benign prostatic hyperplasia.
Topics: Administration, Oral; Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Outcome Assessment, Health Care; Prostatic Hyperplasia; Sulfonamides; Tablets; Taiwan; Tamsulosin; Urodynamics | 2012 |
Alpha-1 adrenergic antagonists in aircrew for the treatment of benign prostatic hypertrophy.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aerospace Medicine; Dehydration; Humans; Lower Urinary Tract Symptoms; Male; Military Personnel; Prostatic Hyperplasia; Sulfonamides; Tamsulosin | 2013 |
Intravesical prostatic protrusion can be a predicting factor for the treatment outcome in patients with lower urinary tract symptoms due to benign prostatic obstruction treated with tamsulosin.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Organ Size; Prostate; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Ultrasonography; Urinary Bladder Neck Obstruction | 2013 |